IL DONG PHARMACEUTICAL CO., LTD.
Develops, manufactures, and commercializes a broad range of healthcare products.
249420 | KO
Overview
Corporate Details
- ISIN(s):
- KR7249420001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 2, 서초구
- Sector:
- Manufacturing
Description
IL DONG PHARMACEUTICAL CO., LTD. is a pharmaceutical company engaged in the research, development, manufacturing, and commercialization of a broad range of healthcare products. The company's portfolio encompasses ethical drugs, over-the-counter (OTC) medications, active pharmaceutical ingredients (APIs), and health functional foods. Key therapeutic areas of focus include metabolic disorders, gastrointestinal diseases, degenerative diseases, oncology, and cardiovascular conditions. Its robust research and development pipeline features promising drug candidates such as an oral GLP-1 receptor agonist for diabetes and obesity, a P-CAB class treatment for peptic ulcers, and a first-in-class CXCR7 agonist for fibrotic diseases. Utilizing its GMP-certified facilities, the company also offers contract manufacturing (CMO) services, with specialized capabilities in antibiotics and oncology drugs, while actively pursuing global expansion through strategic partnerships and licensing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-28 00:00 |
결산실적공시예고(안내공시)
|
Korean | 4.4 KB | ||
| 2024-09-26 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 122.9 KB | ||
| 2024-09-26 00:00 |
최대주주등소유주식변동신고서
|
Korean | 44.3 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.6 MB | ||
| 2024-08-12 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 350.1 KB | ||
| 2024-08-05 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 54.5 KB | ||
| 2024-08-02 00:00 |
공정거래자율준수프로그램운영현황(안내공시)
|
English | 16.2 KB | ||
| 2024-07-31 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.4 KB | ||
| 2024-07-31 00:00 |
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 15.4 KB | ||
| 2024-07-31 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.2 KB | ||
| 2024-07-29 00:00 |
결산실적공시예고(안내공시)
|
Korean | 4.4 KB | ||
| 2024-07-08 00:00 |
[기재정정]사업보고서 (2023.12)
|
Korean | 2.2 MB | ||
| 2024-06-28 00:00 |
지속가능경영보고서등관련사항(자율공시)
|
Korean | 7.6 KB | ||
| 2024-05-31 00:00 |
기업지배구조보고서공시
|
Korean | 1.5 MB | ||
| 2024-05-20 00:00 |
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 10.5 KB |
Automate Your Workflow. Get a real-time feed of all IL DONG PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IL DONG PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IL DONG PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
